Vislink Technologies, Inc. ( NASDAQ: VISL) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ET Mickey Miller - Chief Executive Officer Mike Bond - Chief Financial Officer ...
Too many of us are dying, presenting with it too late ... The Cancer Equals campaign Greene is supporting was launched by ...
Top 15. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the ...
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
Independent re/insurance broker BMS Group has introduced BMS Bacchus, a stock throughput insurance solution designed to ...
Following AbbVie’s announcement, as its stock price fell, BMS’s rose by over 11%. According to GlobalData’s expiry model, ...
The US Food and Drug Administration (FDA) has awarded the second breakthrough therapy designation (BTD) to Johnson & ...
The S&P 500 added 0.1% on Monday, Nov. 11, 2024, closing above the 6,000-point milestone as investors continued to weigh the ...
Bristol-Myers Squibb's Cobenfy comes out as the major beneficiary and will ... and the next steps taken by AbbVie will tell ...
Investing.com - AbbVie (NYSE: ABBV) has announced that its two phase 2 trials of a treatment for adults with schizophrenia ...
Autolus has picked up its first product approval, getting an FDA green light for Aucatzyl as a treatment for patients with ...
Baker Marine Solutions is unveiling its newest towing vessel design and the International WorkBoat Show.The BMS 1882 - A 6000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback